Ototoxicity of erythromycin.
D000293:Adolescent; D004917:Erythromycin / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012874:Skin Diseases, Infectious / Q000188:drug therapy
D004917:Erythromycin